Denali Therapeutics Inc (NASDAQ:DNLI)

23.30
Delayed Data
As of May 24
 -1.15 / -4.71%
Today’s Change
20.24
Today|||52-Week Range
79.70
-47.76%
Year-to-Date
No recent news for Denali Therapeutics Inc.

Today’s Trading

Previous close24.40
Today’s open24.10
Day’s range22.73 - 24.10
Volume454,937
Average volume (3 months)588,228
Market cap$3.0B
Data as of 4:00pm ET, 05/24/2022

Growth & Valuation

Earnings growth (last year)-466.28%
Earnings growth (this year)-10.31%
Earnings growth (next 5 years)--
Revenue growth (last year)-85.50%
P/E ratioNM
Price/Sales111.38
Price/Book3.14

Competitors

----
----
----
BPMCBlueprint Medicines ...-1.58-2.78%
Data as of 4:00pm ET, 05/24/2022

Financials

Next reporting dateAugust 11, 2022
EPS forecast (this quarter)-$0.57
Annual revenue (last year)$48.7M
Annual profit (last year)-$290.6M
Net profit margin-597.15%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Francisco, California

Forecasts